Wikidata

(Q28270294)

English

A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus

scientific article

In more languages

Statements

title
A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus (English)
0 references
author name string
Bernard M Tijink
series ordinal
1
0 references
Jan Buter
series ordinal
2
0 references
Margreet S Lang
series ordinal
5
0 references
Alexander Staab
series ordinal
6
0 references
Guus A M S van Dongen
series ordinal
8
0 references
publication date
15 October 2006
0 references
volume
12
0 references
issue
20 Pt 1
0 references
page(s)
6064-72
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q28270294&oldid=1977976268"